Clinicopathologic Features and Chromosome 12p Status of Pediatric Sacrococcygeal Teratomas: A Multi-institutional Analysis.
Adolescent
Child
Child, Preschool
Chromosomes, Human, Pair 12
/ genetics
Female
Follow-Up Studies
Humans
In Situ Hybridization, Fluorescence
Infant
Infant, Newborn
Isochromosomes
/ genetics
Male
Neoplasms, Germ Cell and Embryonal
/ genetics
Ovarian Neoplasms
/ genetics
Retrospective Studies
Teratoma
/ genetics
Testicular Neoplasms
/ genetics
fluorescence in situ hybridization
germ cell tumor
isochromosome 12p
pediatric patients
sacrococcygeal teratomas extragonadal teratoma
Journal
Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
ISSN: 1615-5742
Titre abrégé: Pediatr Dev Pathol
Pays: United States
ID NLM: 9809673
Informations de publication
Date de publication:
Historique:
pubmed:
5
9
2018
medline:
10
9
2019
entrez:
5
9
2018
Statut:
ppublish
Résumé
Chromosome 12p gains are typically present in postpubertal male patients with testicular malignant germ cell tumors, including most teratomas, and absent in pure ovarian teratomas, both mature and immature. We sought to evaluate the clinicopathologic features and chromosome 12p status of pediatric patients with sacrococcygeal teratomas (SCTs) using the institutional databases of 2 tertiary medical centers. Seven mature teratomas (3 pure, 2 with yolk sac tumor, 1 with medulloepithelioma, and 1 with ependymoma) and 3 immature teratomas (2 pure: grade 2 and grade 3 and 1 mixed: grade 3 with yolk sac tumor) were identified. All patients underwent surgery and 2 received adjuvant chemotherapy. Fluorescence in situ hybridization analysis was performed to elucidate chromosome 12p gains, including isochromosome 12p. All 10 tumors analyzed lacked 12p gains regardless of the components. No patient had evidence of disease at their most recent interval follow-up (mean: 30, range: 7-91 months), irrespective of margin status or of receiving chemotherapy. Overall, our study suggests an absence of chromosome 12p abnormalities in clinically nonaggressive SCTs. Additional data are required to confirm these findings before definitive patient care recommendations can be made.
Identifiants
pubmed: 30176765
doi: 10.1177/1093526618798771
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM